SIETES :: 92381 citas

Resultados de la búsqueda por USA REFINAR BÚSQUEDA

1.

Anónimo. With boxed warning, FDA approves estradiol vaginal inserts for dyspareunia. DIA Daily 2018:2. [Ref.ID 102661]

2.

Grant PJ, Conlon A, Chopra V, Flanders SA. Use of venous thromboembolism prophylaxis in hospitalized patients. JAMA Intern Med 2018:21 de mayo. [Ref.ID 102646]

3.

Park Y, Bateman BT, Kim DH, Hernandez-Diaz S, Patorno E, Glynn RJ, Mogun H, Hyubrechts KF. Use of haloperidol versus atypical antipsychotics and risk of in-hospital death in patients with acute myocardial infarction: cohort study. BMJ 2018;360:28 de marzo. [Ref.ID 102642]

4.

Kioumourtzoglou M-A, Coull BA, O’Reilly EJ, Ascherio A, Weisskopf MG. Association of exposure to diethylstilbestrol during pregnancy with multigenerational neurodevelopmental deficits. JAMA Pediatrics 2018:21 de mayo. [Ref.ID 102638]

5.

Hadland SE, Cerdá M, Li Y, Krieger MS, Marshall BDL. Association of pharmaceutical industry marketing of opioid products to physicians with subsequent opioid prescribing. JAMA Intern Med 2018:14 de mayo. [Ref.ID 102637]

6.

Lyman GH, Zon R, Harvey RD, Schilsky RL. Rationale, opportunities, and reality of biosimilar medications. N Engl J Med 2018;378:24 de mayo. [Ref.ID 102636]

7.

Kaufman DW, Kelly JP, Battista DR, Malone MK, Weinstein RB, Shiffman S. Exceeding the daily dosing limit of nonsteroidal anti-inflammatory drugs among ibuprofen users. Pharmacoepidemiol Drug Saf 2018;27:marzo. [Ref.ID 102633]

8.

Liljenquist D, Bai G, Anderson GF. Addressing generic-drug market failures — The case for establishing a nonprofit manufacturer. N Engl J Med 2018;378:17 de mayo. [Ref.ID 102608]

9.

Feuerstein A. After watching Trump’s drug speech, investors poured big money into biotech funds. STAT Daily Recap 2018:4. [Ref.ID 102605]

10.

Mershon E. Novartis paid Trump’s lawyer’s firm far more than any of its actual lobbyists. STAT 2018:6. [Ref.ID 102601]

11.

Silverman E. ‘Not a good day for Novartis’: CEO tries to reassure employees amid fury over payments to Trump’s lawyer. STAT Daily Recap 2018:1. [Ref.ID 102600]

12.

Silverman E. Trump’s lawyer pitched himself as a fixer to Novartis and got paid $1.2 million. STAT Daily Recap 2018:1. [Ref.ID 102599]

13.

. Novartis paid nearly $400,000 to a shell company controlled by Trump’s attorney. STAT 2018:8 de mayo. [Ref.ID 102598]

14.

Swetlitz I. Gottlieb pushes back against criticism of ‘breakthrough’ designation. STAT Daily Recap 2018:5. [Ref.ID 102595]

15.

Webster P. Pimavanserin evaluated by the FDA. Lancet 2018;391:5 de mayo. [Ref.ID 102594]

16.

Watanabe JH, McInnis T, Hirsch JD. Cost of prescription drug-related morbidity and mortality.. Annals of Pharmacotherapy 2018:26 de marzo. [Ref.ID 102573]

17.

Peter I, Dubinsky M, Bressman S, Park A, Lu C, Chen N, Wang A. Anti–tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease. JAMA Neurology 2018:23 de abril. [Ref.ID 102569]

18.

Wiese AD, Griffin MR, Schaffner W, Stein CM, Greevy RA, Mitchel Jr EF, Grijalva CG. Opioid analgesic use and risk for invasive pneumococcal diseases: a nested case-control study. Ann Intern Med 2018;168:20 de marzo. [Ref.ID 102563]

19.

Hawkes N. Medical textbook authors received £11m in undisclosed payments from drug and device makers. BMJ 2018;360:8 de marzo. [Ref.ID 102548]

20.

Casassus B. Risks of reformulation: French patients complain after Merck modifies levothyroxine pills. BMJ 2018;360:k714. [Ref.ID 102544]